These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20950227)

  • 1. Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking.
    Stavreva N; Nahum A; Markov K; Ruggieri R; Stavrev P
    Acta Oncol; 2010 Nov; 49(8):1324-33. PubMed ID: 20950227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From cell population models to tumor control probability: including cell cycle effects.
    Hillen T; de Vries G; Gong J; Finlay C
    Acta Oncol; 2010 Nov; 49(8):1315-23. PubMed ID: 20843174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor control probability (TCP) in prostate cancer: role of radiobiological parameters and radiation dose escalation.
    Ahmad S; Vogds BJ; McKenna F; Vlachaki MT
    J Xray Sci Technol; 2009; 17(4):347-54. PubMed ID: 19923690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of a TCP model incorporating population heterogeneity.
    Warkentin B; Stavrev P; Stavreva NA; Fallone BG
    Phys Med Biol; 2005 Aug; 50(15):3571-88. PubMed ID: 16030383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability dynamics of a repopulating tumor in case of fractionated external radiotherapy.
    Stavreva N; Stavrev P; Fallone BG
    Phys Med; 2009 Dec; 25(4):181-91. PubMed ID: 19345599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
    Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
    Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
    Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
    J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological effect based treatment plan optimization with the linear quadratic model.
    Schell S; Wilkens JJ; Oelfke U
    Z Med Phys; 2010; 20(3):188-96. PubMed ID: 20832006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
    Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
    Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The interactive determination of the mathematical model parameters for the planning of the radiation therapy of malignant tumors. 2. A method of adjusting the mathematical model parameters for calculating the tolerance doses and probabilities of the occurrence of radiation complications in body organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (5):36-40. PubMed ID: 11076364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.
    Gay HA; Niemierko A
    Phys Med; 2007 Dec; 23(3-4):115-25. PubMed ID: 17825595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the local effect model parameters on the prediction of the tumor control probability for prostate cancer.
    Chanrion MA; Sauerwein W; Jelen U; Wittig A; Engenhart-Cabillic R; Beuve M
    Phys Med Biol; 2014 Jun; 59(12):3019-40. PubMed ID: 24842293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
    Chen Y; Geng J; Tian J; He Y; Chen S
    Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the parameter describing the generalised equivalent uniform dose (gEUD) for tumours.
    Søvik A; Ovrum J; Olsen DR; Malinen E
    Phys Med; 2007 Dec; 23(3-4):100-6. PubMed ID: 17962057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.